Lakefront Biotherapeutics - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Lakefront Biotherapeutics (GLPGF) is 1.58B

According to Lakefront Biotherapeutics’s latest financial reports and current stock price. The company's current Enterprise Value is 1.58B. This represents a change of -7.09% compared to the average of 1.70B of the last 4 quarters.

Lakefront Biotherapeutics (GLPGF) Historical Enterprise Value (quarterly & annually)

How has GLPGF Enterprise Value performed in the past?

The mean historical Enterprise Value of Lakefront Biotherapeutics over the last ten years is 2.84B. The current 1.58B Enterprise Value has changed 5.44% with respect to the historical average. Over the past ten years (40 quarters), GLPGF's Enterprise Value was at its highest in in the December 2019 quarter at 10.02B. The Enterprise Value was at its lowest in in the September 2021 quarter at 151.35M.

Lakefront Biotherapeutics (GLPGF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lakefront Biotherapeutics Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lakefront Biotherapeutics (GLPGF) Average Enterprise Value

How has GLPGF Enterprise Value performed in the past?

The current Enterprise Value of Lakefront Biotherapeutics (GLPGF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lakefront Biotherapeutics (GLPGF) Enterprise Value vs. Peers

How is GLPGF’s Enterprise Value compared to its peers?

Lakefront Biotherapeutics’s Enterprise Value is less than Bavarian Nordic A/S (15.11B), less than Ryman Healthcare Limited (3.60B), less than Bavarian Nordic A/S (15.11B), less than Telix Pharmaceuticals Limited (6.52B), less than Gedeon Richter PLC (2.11T), less than Shandong Weigao Group Medical Polymer Company Limited (9.14B), less than MediPal Holdings Corporation (348.26B), less than Shandong Weigao Group Medical Polymer Company Limited (9.14B), less than Ansell Limited (4.75B), less than Oxford Nanopore Technologies plc (1.60B),

Build a custom stock screener for Lakefront Biotherapeutics (GLPGF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lakefront Biotherapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lakefront Biotherapeutics (GLPGF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lakefront Biotherapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.